| Net income | |
| Amortization in interest expense | 9.8M |
| Compensation on equity grants | 2.2M |
| Interest expense on affiliate and allocated indebtedness | |
| Depreciation and other amortization expense | 563.6M |
| Accretion of asset retirement obligations | 3.5M |
| Deferred income tax expense | 0 |
| Equity in earnings of unconsolidated investment, net of distributions | |
| Risk management activities | 11.7M |
| Receivables and other assets | -28.3M |
| Inventory | -27.8M |
| Accounts payable and other liabilities | 31.8M |
| Net cash provided by operating activities | |
| Outlays for property, plant and equipment | -425M |
| Proceeds from sales of assets | |
| Business acquisition | |
| Investment in unconsolidated affiliate | |
| Unconsolidated affiliate distributions in excess of accumulated earnings | |
| Other, net | 4.2M |
| Net cash used in investing activities | |
| Proceeds from borrowings under credit facility | 1.11B |
| Repayments of credit facility | -1.39B |
| Proceeds from issuance of senior notes | 0 |
| Cash paid on note exchange | |
| Repayment of affiliated and allocated indebtedness | |
| Proceeds from equity offerings | |
| Distributions to unitholders | -542.6M |
| Costs incurred in connection with financing arrangements | |
| Contributions (distributions) from (to) parent | |
| Distributions under common control | |
| Contributions from noncontrolling interests | 32.7M |
| Distributions to noncontrolling interests | -16.8M |
| Net cash used in financing activities | |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | 135.4M |
| Cash and cash equivalents, end of period | 129.9M |